Geron to Present at the 14th Annual Needham Healthcare Conference
Get Alerts GERN Hot Sheet
Join SI Premium – FREE
MENLO PARK, Calif., April 7, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the 14th Annual Needham Healthcare Conference in New York. The presentation is scheduled to occur on Tuesday, April 14, at 5:00 p.m. Eastern Time.
A live webcast of the presentation will be available through the Investor Relations pages of Geron's website or at http://wsw.com/webcast/needham71/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT: Kevin Eng, Ph.D. Investor and Media Relations 650-473-7765 [email protected] [email protected]Source: Geron Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Akanda Appoints Cooper to the Board of Directors
- HRT Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the HireRight Holdings Corp. Class Action
- Perk Labs Announces Closing of Non-Brokered Private Placements
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!